Trial Profile
Phase I testing of ADI-PEG in metastatic melanoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2007
Price :
$35
*
At a glance
- Drugs Pegargiminase (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 19 Aug 2005 New trial record.